Market by Animal Type, Distribution Channel, Route of Administration, Product, and Country | Forecast 2019-2028
The Asia-Pacific veterinary medicines market is estimated to register growth at 5.43% of CAGR during the assessed period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered for evaluation in this market include:
•       India
•       China
•       Japan
•       Australia & New Zealand
•       South Korea
•       ASEAN countries
•       Rest of APAC
In China, the alarming rise in the occurrence of several infectious conditions among animals, including canine distemper and canine parvovirus, is augmenting the veterinary medicines market’s progress. Besides, growing awareness relating to the early diagnosis and treatment of diseases in companion animals is also enhancing the demand for veterinary medicines. Additionally, the country has observed a substantial increase in pet ownership. The animal healthcare expenditure has also grown, owing to the rising disposable income among the population. Hence, these factors indicate the potential growth of the veterinary medicines market across China.
On the other hand, India is highly reliant on its agricultural sector, having a large number of livestock animals. This is one of the significant factors expanding the demand for veterinary medicines in the country, further boosting the studied market’s progress on a large scale. Furthermore, the surge in livestock rearing, owing to the growing demand for meat and milk, as a result of the ever-growing population, is another factor that is expected to boost the demand for veterinary medicines during the projected phase. Therefore, growing livestock production is likely to propel India’s veterinary medicines market on a growth path.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   ASIA-PACIFIC VETERINARY MEDICINES MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1.  THREAT OF NEW ENTRANTS
2.2.2.  THREAT OF SUBSTITUTE PRODUCTS
2.2.3.  BARGAINING POWER OF BUYERS
2.2.4.  BARGAINING POWER OF SUPPLIERS
2.2.5.  THREAT OF COMPETITIVE RIVALRY
2.3. INDUSTRY COMPONENTS
2.4. LEGAL POLICY AND REGULATORY FRAMEWORK
2.5. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1.  RISE IN LIVESTOCK PRODUCTION
2.8.2.  SURGE IN VARIOUS MEDICAL CONDITIONS IN ANIMALS
2.8.3.  INCREASING OWNERSHIP OF PETS
2.9. MARKET RESTRAINTS
2.9.1.  ADVERSE EFFECTS OF POST-VACCINATION
2.9.2.  LACK OF ADEQUATE NUMBER OF VETERINARIANS
2.10. MARKET OPPORTUNITIES
2.10.1. GROWING ANIMAL HEALTHCARE EXPENDITURE
2.10.2.  INCREASING DEMAND FOR VETERINARY SPECIALIZATION
2.11. MARKET CHALLENGES
2.11.1. STRINGENT REGULATIONS
2.11.2. HIGH COST OF ANIMAL VACCINES
3.   ASIA-PACIFIC VETERINARY MEDICINES MARKET OUTLOOK - BY ANIMAL TYPE
3.1. COMPANION ANIMALS
3.2. LIVESTOCK ANIMALS
4.   ASIA-PACIFIC VETERINARY MEDICINES MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
4.1. RETAIL VETERINARY PHARMACIES
4.2. VETERINARY HOSPITAL PHARMACIES
5.   ASIA-PACIFIC VETERINARY MEDICINES MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
5.1. PARENTERAL ROUTE
5.2. ORAL ROUTE
5.3. TOPICAL ROUTE
6.   ASIA-PACIFIC VETERINARY MEDICINES MARKET OUTLOOK - BY PRODUCT
6.1. DRUGS
6.1.1.  ANTI-INFECTIVE
6.1.2.  ANTI-INFLAMMATORY
6.1.3.  PARASITICIDE
6.2. VACCINES
6.2.1.  INACTIVATED VACCINES
6.2.2.  ATTENUATED VACCINES
6.2.3.  RECOMBINANT VACCINES
6.3. MEDICATED FEED ADDITIVES
6.3.1.  ANTIBIOTICS
6.3.2.  AMINO ACIDS
7.   GEOGRAPHICAL ANALYSIS - ASIA-PACIFIC
7.1. COUNTRY ANALYSIS
7.1.1.  CHINA
7.1.2.  JAPAN
7.1.3.  AUSTRALIA & NEW ZEALAND
7.1.4.  INDIA
7.1.5.  SOUTH KOREA
7.1.6.  ASEAN COUNTRIES
7.1.7.  REST OF ASIA-PACIFIC
8.   COMPANY PROFILES
8.1. EVONIK INDUSTRIES AG (RAG STIFTUNG)
8.2. INDIAN IMMUNOLOGICALS LIMITED
8.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
8.4. MERCK & CO
8.5. ZOETIS
8.6. BIOGENESIS BAGO SA
8.7. VETOQUINOL (SOPARFIN SCA)
8.8. ARCHER DANIELS MIDLAND
8.9. CEVA SANTE ANIMALE
8.10. VIRBAC SA
8.11. DECHRA PHARMACEUTICALS PLC
8.12. NEOGEN CORPORATION
8.13. ELANCO
8.14. HESTER BIOSCIENCES LIMITED
8.15. KINDRED BIOSCIENCES
9.   RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1.  OBJECTIVES OF STUDY
9.1.2.  SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1.  PRIMARY DATA SOURCES
9.2.2.  SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1.  EVALUATION OF PROPOSED MARKET
9.3.2.  IDENTIFICATION OF DATA SOURCES
9.3.3.  ASSESSMENT OF MARKET DETERMINANTS
9.3.4.  DATA COLLECTION
9.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: ASIA-PACIFIC VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)Â Â Â Â Â Â
FIGURE 1: ASIA-PACIFIC VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 3: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
FIGURE 20: CHINA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 21: JAPAN VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 22: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 23: INDIA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 24: SOUTH KOREA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 25: ASEAN COUNTRIES’ VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 26: REST OF ASIA-PACIFIC VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)